Independent survey reveals Renuvion is #1
trusted body contouring technology* with plastic and cosmetic
surgeons.
CLEARWATER, Fla., Aug. 13,
2024 /PRNewswire/ -- Apyx® Medical
Corporation (NASDAQ: APYX) ("Apyx Medical;" the "Company"), a
leader in advanced energy technology and the manufacturer of
Renuvion®, today announced that doctors named Renuvion
as the #1 trusted body contouring technology in an independent
survey by Wakefield Research.** This recognition underscores
the effectiveness of Renuvion's novel technology that targets loose
skin at the source, offering unparalleled results for body
contouring procedures.
Renuvion is the first and only body contouring technology
that empowers consumers to feel and look their best, from the
inside out by targeting loose skin. Renuvion brings
evidence-based medicine to plastic surgery and as such, has
garnered a global fan base of respected plastic surgeons around the
world.
"The plastic surgery industry is built on trust and results,
which is why we are dedicated to providing surgeons with the best
technology focused on precision, safety, and results backed by
90-plus clinical papers and the most peer-reviewed studies," said
Charlie Goodwin, President and Chief
Executive Officer. "We're proud to be the technology surgeons use
and trust to provide durable, transformative outcomes for
patients."
In the U.S., Renuvion is increasingly being used by plastic
surgeons in a time when consumer demand for plastic
surgeon-performed procedures continues to rise. Over the past two
years, the Apyx Medical team has secured four FDA 510(k) clearances
which highlights the company's commitment to providing
evidence-based outcomes through advanced technology in the hands of
plastic surgeons. Since Renuvion launched into market, more than
350,000 patients have been treated with Renuvion to change the way
people feel physically, mentally, and emotionally.
In addition to being named the #1 trusted body contouring
technology, 4 out of 5 surgeons prefer Renuvion over other
treatments to follow liposuction, which, of the nearly 2.3 million
cosmetic surgical procedures performed in 2023, was the number one
most common.*** Renuvion is the only device that is FDA-cleared for
contracting subcutaneous tissue and the only device that is
FDA-cleared for use after liposuction, providing people with a
proven solution for loose skin.
*In a survey where 4 out of 5 surgeons agree.
**Of 200 unaffiliated board certified or eligible cosmetic and
plastic surgeons in the US.
***2023 ISAPS International Survey on Aesthetic/Cosmetic
Procedures
About Apyx Medical
Corporation:
Apyx Medical Corporation is an
advanced energy technology company with a passion for elevating
people's lives through innovative products, including its Helium
Plasma Platform Technology products marketed and sold as Renuvion
in the cosmetic surgery market and J-Plasma® in the
hospital surgical market. Renuvion and J-Plasma offer surgeons a
unique ability to provide controlled heat to tissue to achieve
their desired results. The effectiveness of Renuvion and J-Plasma
are supported by more than 90 clinical documents. The Company also
leverages its deep expertise and decades of experience in unique
waveforms through OEM agreements with other medical device
manufacturers. For further information about the Company and its
products, please refer to the Apyx Medical
Corporation website www.ApyxMedical.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/renuvion-named-1-trusted-body-contouring-technology-by-doctors-302220441.html
SOURCE Apyx Medical Corporation